Drug
Tirbanibulin G
Tirbanibulin G: highest development phase Post-Market, developed by Almirall. 1 trial record tracked on RxWires.
- Highest phase
- Post-Market
- Developer
- Almirall
Trials
| Drug | Phase | Indication |
|---|---|---|
| Tirbanibulin (Klisyri®) 10 mg/g ointment NCT05387525 | Post-Market | Keratosis, Actinic |
Latest
No recent events.
Follow Tirbanibulin G on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.